Bie, Y., Wang, J., Xiong, L., Wang, D., Liao, J., Zhang, Y., & Lin, H. (2021). Lung adenocarcinoma organoids harboring EGFR 19Del and L643V double mutations respond to osimertinib and gefitinib: A case report. Medicine (Baltimore).
Styl ChicagoBie, Yanan, Jin Wang, Linmin Xiong, Dong Wang, Jing Liao, Yelin Zhang, a Hang Lin. "Lung Adenocarcinoma Organoids Harboring EGFR 19Del and L643V Double Mutations Respond to Osimertinib and Gefitinib: A Case Report." Medicine (Baltimore) 2021.
Citace podle MLABie, Yanan, et al. "Lung Adenocarcinoma Organoids Harboring EGFR 19Del and L643V Double Mutations Respond to Osimertinib and Gefitinib: A Case Report." Medicine (Baltimore) 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..